Pacific Bio (PACB) Reports Q4 Revenues of $24.9 Million
Pacific Bio (NASDAQ: PACB) reported Q4 revenue of $24.9 million, versus $24.4 million reported last year.
For earnings history and earnings-related data on Pacific Bio (PACB) click here.
Pacific Bio (NASDAQ: PACB) reported Q4 revenue of $24.9 million, versus $24.4 million reported last year.
For earnings history and earnings-related data on Pacific Bio (PACB) click here.